Pazopanib Impurity 16

Product Description
CAT No.
ALN-P013024
CAS No.
1821666-74-3
Mol. F.
C21H23N7O3S
Mol. Wt.
453.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 2,3-dimethyl-6-(methyl(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)amino)-2H-indazole 2-oxide
Smiles : CC1=C(S(=O)(N)=O)C=C(NC2=NC(N(C)C3=CC4=N[N+]([O-])(C)C(C)=C4C=C3)=CC=N2)C=C1
Inchi : InChI=1/C21H23N7O3S/c1-13-5-6-15(11-19(13)32(22,30)31)24-21-23-10-9-20(25-21)28(4,29)16-7-8-17-14(2)27(3)26-18(17)12-16/h5-12H,1-4H3,(H2,22,30,31)(H,23,24,25)
Technical Data
Reference
Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mapping
Yan Li 1, David Q Liu, Shawn Yang, Ravinder Sudini, Michael A McGuire, Dharmesh S Bhanushali, Alireza S KordnJ Pharm Biomed Anal. 2010 Aug 1;52(4):493-507.
Determination and characterization of process impurities in pazopanib hydrochloride drug substance
musty sharada, ravichandra babu – Int J Pharm Pharm Sci, Vol 8, Issue 4, 97-102
Characterization of forced degradation products of pazopanib hydrochloride by UHPLC?Q?TOF/MS and in silico toxicity prediction
Prinesh N. Patel\xa0 Pradipbhai D. Kalariya\xa0 Mahesh Sharma\xa0 Prabha Garg\xa0 M. V. N Kumar Talluri\xa0 S. Gananadhamu\xa0 R. Srinivas – Journal of mass spectrometry Volume50, Issue7 July 2015 Pages 918-928
RFQ